Literature DB >> 9516436

Inhibition of the hepatitis C virus helicase-associated ATPase activity by the combination of ADP, NaF, MgCl2, and poly(rU). Two ADP binding sites on the enzyme-nucleic acid complex.

D J Porter1.   

Abstract

Hepatitis C virus (HCV) helicase has an intrinsic ATPase activity and a nucleic acid (poly(rU))-stimulated ATPase activity. The poly(rU)-stimulated ATPase activity was inhibited by F- in a time-dependent manner during ATP hydrolysis. Inhibition was the result of trapping an enzyme-bound ADP-poly(rU) ternary complex generated during the catalytic cycle and was not the result of generating enzyme-free ADP that subsequently inhibited the enzyme. However, catalysis was not required for efficient inhibition by F-. The stimulated and the intrinsic ATPase activities were also inhibited by treatment of the enzyme with F-, ADP, and poly(rU). The inhibited enzyme slowly recovered (t1/2 = 23 min) ATPase activity after a 2000-fold dilution into assay buffer. The onset of inhibition by 500 microM ADP and 15 mM F- in the absence of nucleic acid was very slow (t1/2 > 40 min). However, the sequence of addition of poly(rU) to a diluted solution of ADP/NaF-treated enzyme had a profound effect on the extent of inhibition. If the ADP/NaF-treated enzyme was diluted into an assay that lacked poly(rU) and the assay was subsequently initiated with poly(rU), the treated enzyme was not inhibited. Alternatively, if the treated enzyme was diluted into an assay containing poly(rU), the enzyme was inhibited. ATP protected the enzyme from inhibition by ADP/NaF. The stoichiometry between ADP and enzyme monomer in the inhibited enzyme complex was 2, as determined from titration of the ATPase activity ([ADP]/[E] = 2.2) and from the number of radiolabeled ADP bound to the inhibited enzyme ([ADP]/[E] = 1.7) in the presence of excess NaF, MgCl2, and poly(rU). The Hill coefficient for titration of ATPase activity with F- (n = 2.8) or MgCl2 (n = 2.1) in the presence of excess ADP and poly(rU) suggested that multiple F- and Mg2+ were involved in forming the inhibited enzyme complex. The stoichiometry between (dU)18, a defined oligomeric nucleic acid substituting for poly(rU), and enzyme monomer in the inhibited enzyme complex was estimated to be 1 ([(dU)18/[E] = 1.2) from titration of the ATPase activity in the presence of excess ADP, MgCl2, and NaF.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9516436     DOI: 10.1074/jbc.273.13.7390

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

Review 1.  Perspectives for the treatment of infections with Flaviviridae.

Authors:  P Leyssen; E De Clercq; J Neyts
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

Review 2.  Understanding helicases as a means of virus control.

Authors:  D N Frick; A M I Lam
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

3.  Structure-based mutagenesis study of hepatitis C virus NS3 helicase.

Authors:  C Lin; J L Kim
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

4.  Role of divalent metal cations in ATP hydrolysis catalyzed by the hepatitis C virus NS3 helicase: magnesium provides a bridge for ATP to fuel unwinding.

Authors:  David N Frick; Sukalyani Banik; Ryan S Rypma
Journal:  J Mol Biol       Date:  2006-11-07       Impact factor: 5.469

5.  Two novel conserved motifs in the hepatitis C virus NS3 protein critical for helicase action.

Authors:  Angela M I Lam; David Keeney; David N Frick
Journal:  J Biol Chem       Date:  2003-08-27       Impact factor: 5.157

6.  Localisation of the human hSuv3p helicase in the mitochondrial matrix and its preferential unwinding of dsDNA.

Authors:  Michal Minczuk; Jan Piwowarski; Monika A Papworth; Karen Awiszus; Sarah Schalinski; Andrzej Dziembowski; Aleksandra Dmochowska; Ewa Bartnik; Kostas Tokatlidis; Piotr P Stepien; Peter Borowski
Journal:  Nucleic Acids Res       Date:  2002-12-01       Impact factor: 16.971

Review 7.  The hepatitis C virus NS3 protein: a model RNA helicase and potential drug target.

Authors:  David N Frick
Journal:  Curr Issues Mol Biol       Date:  2007-01       Impact factor: 2.081

Review 8.  Viral and cellular RNA helicases as antiviral targets.

Authors:  Ann D Kwong; B Govinda Rao; Kuan-Teh Jeang
Journal:  Nat Rev Drug Discov       Date:  2005-10       Impact factor: 84.694

9.  Phosphate release contributes to the rate-limiting step for unwinding by an RNA helicase.

Authors:  Qixin Wang; Jamie J Arnold; Akira Uchida; Kevin D Raney; Craig E Cameron
Journal:  Nucleic Acids Res       Date:  2009-12-06       Impact factor: 16.971

10.  Bismuth complexes inhibit the SARS coronavirus.

Authors:  Nan Yang; Julian A Tanner; Bo-Jian Zheng; Rory M Watt; Ming-Liang He; Lin-Yu Lu; Jie-Qing Jiang; Ka-To Shum; Yong-Ping Lin; Kin-Ling Wong; Marie C M Lin; Hsiang-Fu Kung; Hongzhe Sun; Jian-Dong Huang
Journal:  Angew Chem Int Ed Engl       Date:  2007       Impact factor: 15.336

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.